Lodestar Minerals advances Ned's Creek gold on back of high-grade Central Park results
Lodestar Minerals has received further encouraging assay results from the Central Park prospect within the Ned’s Creek gold project in WA.
Market Cap $639.1M
!
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Last update - 16.25pm 31/07/2026 (20 minute delay)
?
| Day | ||||||||
|---|---|---|---|---|---|---|---|---|
| Open | $4.31 | Day High | $4.38 | Day Low | $4.02 | |||
| Daily Volume | 1430168 | |||||||
| Bids | Sellers | |||||
|---|---|---|---|---|---|---|
| Number | Price | Volume | Number | Price | Volume | |
| 0 | $4.02 | 1456 | 0 | $4.10 | 9232 | |
Directors & Senior Management
| Mr. Bernard William Ridgeway | Executive Chair |
| Ms. Catherine Jane Hill | Independent Non-Executive Director |
| Prof. Girish Dwivedi | Chief Scientific Officer |
| Dr. Jacque J. Sokolov | Independent Director |
| Dr. Jeffrey D. LeBenger | Non-Executive Director |
| Mr. John Konstantopoulos | Co-Founder & CEO |
| Mr. Mark Edward Pitts | Company Secretary |
| Phil Bowen | Chief Operations Officer |
| Dr. Richard M. Stewart | Chief Regulatory Affairs & Quality Officer |
| Mr. Richard Mark Jarvis | Interim Chief Financial Officer |
| Ryan Athearn | Head of Global Clinical Operations |
Data source: ADVFN
